KORE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now for an impatient investor: at ~$4.95 pre-market, the stock is already essentially at the $5.00 take-private offer \u201ccap,\u201d leaving minimal upside versus meaningful downside if the deal stalls or breaks.", "Risk/reward is asymmetric at this price (roughly ~1% upside to $5 vs. potentially much larger downside if the transaction fails and fundamentals reassert).", "With no Intellectia buy signals today and weakening momentum (negative, expanding MACD histogram), there\u2019s no technical/signal-based edge to justify chasing here."]
["Price/levels: Pre-market ~$4.95; pivot 4.883. Immediate resistance R1 ~5.20 and take-private offer level at $5.00 effectively acts as a near-term ceiling.", "Trend: Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), indicating an underlying uptrend/price support.", "Momentum: MACD histogram is negative (-0.0054) and negatively expanding, suggesting bearish momentum is building despite the bullish MA stack.", "RSI: RSI_6 ~56.96 (neutral), no strong overbought/oversold signal.", "Support: S1 ~4.566 then S2 ~4.37\u2014key downside zones if the deal narrative weakens.", "Quant pattern read-through: Similar-pattern probabilities imply mild negative drift (-1.15% 1-week; -1.44% 1-month), not supportive of an aggressive entry at the top of the range.", "Intellectia Proprietary Trading Signals\n- AI Stock Picker: no signal on given stock today.\n- SwingMax: No signal on given stock recently."]
["Non-binding $5.00/share take-private offer from Searchlight and Abry provides near-term price support.", "Analyst commentary suggests the offer level may be a reference \u201cfloor/anchor\u201d while the process plays out.", "Gross margin improved YoY to 35.3% (+1.44% YoY), a modest operational positive."]
["Deal risk: the offer is non-binding; if the transaction is delayed/doesn\u2019t close, the stock can re-rate downward quickly.", "Fundamentals softened: management withdrew guidance and trends were described as softer-than-expected by an analyst.", "Momentum deterioration: MACD is negative and worsening, which can pressure near-term price action even in a broader uptrend.", "No fresh news catalysts in the last week to drive a quick upside breakout beyond the offer-implied cap."]
["Latest quarter: 2025/Q3.", "Revenue: $68.692M, down -0.33% YoY (flat-to-slightly negative growth).", "Net income: -$12.707M, down -34.53% YoY (loss widened).", "EPS: -$0.64, down -36.00% YoY (deterioration).", "Gross margin: 35.3%, up +1.44% YoY (the main bright spot, but not enough to offset earnings decline)."]
["2025-11-13 TD Cowen: Hold; price target raised to $5 from $3, explicitly aligning with the $5 take-private offer; noted Q3 miss and guidance withdrawal.", "2025-11-13 Roth Capital: Buy; price target cut to $5 from $9, also anchoring to the $5 offer; expects the transaction likely consummates and views another bidder as unlikely.", "Wall Street pro view (pros): offer provides support and a clear reference value; some confidence the deal closes.", "Wall Street pro view (cons): underlying business trends disappointed (Q3 miss, guidance pulled); upside is capped near $5, limiting attractiveness for new buyers at ~$4.95."]
